|
1
|
World Health Organization. The Global
Burden of Disease: 2004 Update. World Health Organization, Geneva,
2008. Available from: https://www.who.int/publications/i/item/9789241563710.
|
|
2
|
Maier W, Gänsicke M, Gater R, Rezaki M,
Tiemens B and Urzúa RF: Gender differences in the prevalence of
depression: A survey in primary care. J Affect Disord. 53:241–252.
1999.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Angold A, Costello EJ and Worthman CM:
Puberty and depression: The roles of age, pubertal status and
pubertal timing. Psychol Med. 28:51–61. 1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuehner C: Gender differences in unipolar
depression: An update of epidemiological findings and possible
explanations. Acta Psychiatr Scand. 108:163–174. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dwyer JB, Aftab A, Radhakrishnan R, Widge
A, Rodriguez CI, Carpenter LL, Nemeroff CB, McDonald WM and Kalin
NH: APA Council of Research Task Force on Novel Biomarkers and
Treatments. Hormonal treatments for major depressive disorder:
State of the art. Am J Psychiatry. 177:686–705. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hammond GL: Plasma steroid-binding
proteins: Primary gatekeepers of steroid hormone action. J
Endocrinol. 230:R13–R25. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bean LA, Ianov L and Foster TC: Estrogen
receptors, the hippocampus, and memory. Neuroscientist. 20:534–545.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Garcia-Segura LM, Azcoitia I and DonCarlos
LL: Neuroprotection by estradiol. Prog Neurobiol. 63:29–60.
2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Behl C and Manthey D: Neuroprotective
activities of estrogen: An update. J Neurocytol. 29:351–358.
2000.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kulkarni J: Oestrogen and neuroprotection.
Aust NZJ Psychiatry. 45(604)2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Toffoletto S, Lanzenberger R, Gingnell M,
Sundström-Poromaa I and Comasco E: Emotional and cognitive
functional imaging of estrogen and progesterone effects in the
female human brain: A systematic review. Psychoneuroendocrinology.
50:28–52. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sundström-Poromaa I, Comasco E, Sumner R
and Luders E: Progesterone-friend or foe? Front Neuroendocrinol.
59(100856)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gundlah C, Lu NZ and Bethea CL: Ovarian
steroid regulation of monoamine oxidase-A and -B mRNAs in the
macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology
(Berl). 160:271–282. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Koldzic-Zivanovic N, Seitz PK, Watson CS,
Cunningham KA and Thomas ML: Intracellular signaling involved in
estrogen regulation of serotonin reuptake. Mol Cell Endocrinol.
226:33–42. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Halbreich U and Kahn LS: Role of estrogen
in the aetiology and treatment of mood disorders. CNS Drugs.
15:797–817. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
American Psychiatric Association (APA):
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th
edition. American Psychiatric Association, Washington, DC,
1994.
|
|
17
|
American Psychiatric Association
Publishing: Diagnostic and Statistical Manual of Mental Disorders:
DSM-5. 5th edition. https://repository.poltekkes-kaltim.ac.id/657/1/Diagnostic%20and%20statistical%20manual%20of%20mental%20disorders%20_%20DSM-5%20(%20PDFDrive.com%20).pdf,
2013.
|
|
18
|
Li Y, Pehrson AL, Budac DP, Sánchez C and
Gulinello M: A rodent model of premenstrual dysphoria: Progesterone
withdrawal induces depression-like behavior that is differentially
sensitive to classes of antidepressants. Behav Brain Res.
234:238–247. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Klatzkin RR, Morrow AL, Light KC, Pedersen
CA and Girdler SS: Histories of depression, allopregnanolone
responses to stress, and premenstrual symptoms in women. Biol
Psychol. 71:2–11. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lopez LM, Kaptein AA and Helmerhorst FM:
Oral contraceptives containing drospirenone for premenstrual
syndrome. Cochrane Database Syst Rev. 15(CD006586)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Witjes H, Creinin MD, Sundström-Poromaa I,
Martin Nguyen A and Korver T: Comparative analysis of the effects
of nomegestrol acetate/17 β-estradiol and
drospirenone/ethinylestradiol on premenstrual and menstrual
symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care.
20:296–307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
No authors listed. Committee opinion No.
642: Increasing access to contraceptive implants and intrauterine
devices to reduce unintended pregnancy. Obstet Gynecol.
126:e44–e48. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hatcher RA: Contraceptive Technology. 21st
edition. Atlanta, Managing Contraception, LLC, 2018.
|
|
24
|
Mansour D, Korver T, Marintcheva-Petrovna
M and Fraser IS: The effects of Implanon on menstrual bleeding
patterns. Eur J Contracept Reprod Health Care. 13 (Suppl
1):S13–S28. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kavanaugh ML and Jerman J: Contraceptive
method use in the United States: Trends and characteristics
between. 2008, 2012 and 2014. Contraception. 97:14–21.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
McCloskey LR, Wisner KL, Cattan MK,
Betcher HK, Stika CS and Kiley JW: Contraception for women with
psychiatric disorders. Am J Psychiatry. 178:247–255.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Trussell J: Contraceptive failure in the
United States. Contraception. 83:397–404. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
No authors listed. ACOG practice bulletin
No. 110: Noncontraceptive uses of hormonal contraceptives. Obstet
Gynecol. 115:206–218. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mu E and Kulkarni J: Hormonal
contraception and mood disorders. Aust Prescr. 45:75–79.
2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Montoya ER and Bos PA: How oral
contraceptives impact social-emotional behavior and brain
functions. Trends Cogn Sci. 21:125–136. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Doornweerd AM, Branje S, Nelemans SA,
Meeus WHJ, Montoya ER, Engelhard IM, Baas JMP and Gerritsen L:
Stable anxiety and depression trajectories in late adolescence for
oral contraceptive users. Front Psychiatry.
13(799470)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Anderl C, Li G and Chen FS: Oral
contraceptive use in adolescence predicts lasting vulnerability to
depression in adulthood. J Child Psychol Psychiatry. 61:148–156.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Skovlund CW, Mørch LS, Kessing LV and
Lidegaard Ø: Association of hormonal contraception with depression.
JAMA Psychiatry. 73:1154–1162. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Anderl C, de Wit AE, Giltay EJ, Oldehinkel
AJ and Chen FS: Association between adolescent oral contraceptive
use and future major depressive disorder: A prospective cohort
study. J Child Psychol Psychiatry. 63:333–341. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bengtsdotter H, Lundin C, Gemzell
Danielsson K, Bixo M, Baumgart J, Marions L, Brynhildsen J,
Malmborg A, Lindh I and Sundström Poromaa I: Ongoing or previous
mental disorders predispose to adverse mood reporting during
combined oral contraceptive use. Eur J Contracept Reprod Health
Care. 23:45–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Johansson T, Vinther Larsen S, Bui M, Ek
WE, Karlsson T and Johansson Å: Population-based cohort study of
oral contraceptive use and risk of depression. Epidemiol Psychiatr
Sci. 32(e39)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gawronska J, Meads C, Smith L, Cao C, Wang
N and Walker S: Association of oral contraceptive pill use and
depression among US women. J Affect Disord. 344:132–140.
2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Scheuringer A, Lundin C, Derntl B, Pletzer
B and Sundström Poromaa I: Use of an estradiol-based combined oral
contraceptives has no influence on attentional bias or depressive
symptoms in healthy women. Psychoneuroendocrinology.
113(104544)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rapkin AJ, Morgan M, Sogliano C, Biggio G
and Concas A: Decreased neuroactive steroids induced by combined
oral contraceptive pills are not associated with mood changes.
Fertil Steril. 85:1371–1378. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Morssinkhof MWL, Lamers F, Hoogendoorn AW,
de Wit AE, Riese H, Giltay EJ, van den Heuvel OA, Penninx BW and
Broekman BFP: Oral contraceptives, depressive and insomnia symptoms
in adult women with and without depression.
Psychoneuroendocrinology. 133(105390)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Edwards AC, Lönn SL, Crump C, Mościcki EK,
Sundquist J, Kendler KS and Sundquist K: Oral contraceptive use and
risk of suicidal behavior among young women. Psychol Med.
52:1710–1717. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Skovlund CW, Mørch LS, Kessing LV, Lange T
and Lidegaard O: Association of hormonal contraception with suicide
attempts and suicides. Am J Psychiatry. 175:336–342.
2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ko JY, Farr SL, Dietz PM and Robbins CL:
Depression and treatment among U.S. pregnant and nonpregnant women
of reproductive age, 2005-2009. J Womens Health (Larchmt).
21:830–836. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Marcus SM: Depression during pregnancy:
Rates, risks and consequences-motherisk update 2008. Can J Clin
Pharmacol. 16:e15–e22. 2009.PubMed/NCBI
|
|
45
|
Vesga-López O, Blanco C, Keyes K, Olfson
M, Grant BF and Hasin DS: Psychiatric disorders in pregnant and
postpartum women in the United States. Arch Gen Psychiatry.
65:805–815. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gavin NI, Gaynes BN, Lohr KN,
Meltzer-Brody S, Gartlehner G and Swinson T: Perinatal depression:
A systematic review of prevalence and incidence. Obstet Gynecol.
106:1071–1083. 2005.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Silverman ME, Reichenberg A, Savitz DA,
Cnattingius S, Lichtenstein P, Hultman CM, Larsson H and Sandin S:
The risk factors for postpartum depression: A population-based
study. Depress Anxiety. 34:178–187. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Schiller CE, Meltzer-Brody S and Rubinow
DR: The role of reproductive hormones in postpartum depression. CNS
Spectr. 20:48–59. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Galea LA, Wide JK and Barr AM: Estradiol
alleviates depressive-like symptoms in a novel animal model of
post-partum depression. Behav Brain Res. 122:1–9. 2001.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Stoffel EC and Craft RM: Ovarian hormone
withdrawal-induced ‘depression’ in female rats. Physiol Behav.
83:505–513. 2004.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Suda S, Segi-Nishida E, Newton SS and
Duman RS: A postpartum model in rat: Behavioral and gene expression
changes induced by ovarian steroid deprivation. Biol Psychiatry.
64:311–319. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Amin Z, Canli T and Epperson CN: Effect of
estrogen-serotonin interactions on mood and cognition. Behav Cogn
Neurosci Rev. 4:43–58. 2005.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Schiller CE, O'Hara MW, Rubinow DR and
Johnson AK: Estradiol modulates anhedonia and behavioral despair in
rats and negative affect in a subgroup of women at high risk for
postpartum depression. Physiol Behav. 119:137–144. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Bloch M, Schmidt PJ, Danaceau M, Murphy J,
Nieman L and Rubinow DR: Effects of gonadal steroids in women with
a history of postpartum depression. Am J Psychiatry. 157:924–930.
2000.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Schiller CE, Walsh E, Eisenlohr-Moul TA,
Prim J, Dichter GS, Schiff L, Bizzell J, Slightom SL, Richardson
EC, Belger A, et al: Effects of gonadal steroids on reward
circuitry function and anhedonia in women with a history of
postpartum depression. J Affect Disord. 314:176–184.
2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mehta D, Newport DJ, Frishman G, Kraus L,
Rex-Haffner M, Ritchie JC, Lori A, Knight BT, Stagnaro E, Ruepp A,
et al: Early predictive biomarkers for postpartum depression point
to a role for estrogen receptor signaling. Psychol Med.
44:2309–2322. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Möhler H: Faculty opinions recommendation
of Brexanolone Injection in post-partum depression: Two
multicentre, double-blind, randomised, placebo-controlled, phase 3
trials. Faculty Opinions-Post-Publication Peer Review of the
Biomedical Literature, 2019. Available from: https://doi.org/10.3410/f.733945711.793560291.
|
|
58
|
Kroska EB and Stowe ZN: Postpartum
depression: Identification and treatment in the clinic setting.
Obstet Gynecol Clin North Am. 47:409–419. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Li HJ, Martinez PE, Li X, Schenkel LA,
Nieman LK, Rubinow DR and Schmidt PJ: Transdermal estradiol for
postpartum depression: Results from a pilot randomized,
double-blind, placebo-controlled study. Arch Womens Ment Health.
23:401–412. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Soules MR, Sherman S, Parrott E, Rebar R,
Santoro N, Utian W and Woods N: Executive summary: Stages of
reproductive aging workshop (STRAW). Fertil Steril. 76:874–877.
2001.PubMed/NCBI
|
|
61
|
Shifren JL and Schiff I: The aging ovary.
J Womens Health Gend Based Med. 9 (Suppl 1):S3–S7. 2000.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Soares CN, Poitras JR and Prouty J: Effect
of reproductive hormones and selective estrogen receptor modulators
on mood during menopause. Drugs Aging. 20:85–100. 2003.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Ryan J, Scali J, Carrière I, Peres K,
Rouaud O, Scarabin PY, Ritchie K and Ancelin ML: Oestrogen receptor
polymorphisms and late-life depression. Br J Psychiatry.
199:126–131. 2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Freeman EW, Sammel MD, Liu L, Gracia CR,
Nelson DB and Hollander L: Hormones and menopausal status as
predictors of depression in women in transition to menopause. Arch
Gen Psychiatry. 61:62–70. 2004.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Bromberger JT, Kravitz HM, Chang YF,
Cyranowski JM, Brown C and Matthews KA: Major depression during and
after the menopausal transition: Study of women's health across the
nation (SWAN). Psychol Med. 41:1879–1888. 2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Bromberger JT, Schott L, Kravitz HM and
Joffe H: Risk factors for major depression during midlife among a
community sample of women with and without prior major depression:
Are they the same or different? Psychol Med. 45:1653–1664.
2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Freeman EW, Sammel MD, Lin H and Nelson
DB: Associations of hormones and menopausal status with depressed
mood in women with no history of depression. Arch Gen Psychiatry.
63:375–382. 2006.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Freeman EW: Associations of depression
with the transition to menopause. Menopause. 17:823–827.
2010.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Freeman EW, Sammel MD, Boorman DW and
Zhang R: Longitudinal pattern of depressive symptoms around natural
menopause. JAMA Psychiatry. 71:36–43. 2014.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Schmidt PJ and Rubinow DR: Sex hormones
and mood in perimenopause. Ann N Y Acad Sci. 1179:70–85.
2009.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Badawy Y, Spector A, Li Z and Desai R: The
risk of depression in the menopausal stages: A systematic review
and meta-analysis. J Affect Disord. 357:126–133. 2024.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Harlow BL, Wise LA, Otto MW, Soares CN and
Cohen LS: Depression and its influence on reproductive endocrine
and menstrual cycle markers associated with perimenopause: The
harvard study of moods and cycles. Arch Gen Psychiatry. 60:29–36.
2003.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Morrison MF, Kallan MJ, Ten HT, Katz I,
Tweedy K and Battistini M: Lack of efficacy of estradiol for
depression in postmenopausal women: A randomized, controlled trial.
Biol Psychiatry. 55:406–412. 2004.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Gordon JL, Rubinow DR, Eisenlohr-Moul TA,
Xia K, Schmidt PJ and Girdler SS: Efficacy of transdermal estradiol
and micronized progesterone in the prevention of depressive
symptoms in the menopause transition: A randomized clinical trial.
JAMA Psychiatry. 75:149–157. 2018.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Geiger PJ, Eisenlohr-Moul T, Gordon JL,
Rubinow DR and Girdler SS: Effects of perimenopausal transdermal
estradiol on self-reported sleep, independent of its effect on
vasomotor symptom bother and depressive symptoms. Menopause.
26:1318–1323. 2019.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Wium-Andersen MK, Jørgensen TSH, Halvorsen
AH, Hartsteen BH, Jørgensen MB and Osler M: Association of hormone
therapy with depression during menopause in a cohort of Danish
women. JAMA Netw Open. 5(e2239491)2022.PubMed/NCBI View Article : Google Scholar
|
